Genetic ablation of ST2 could remarkably reduce Treg density, but enhance the density of effector CD8 positive T cells in the tumor microenvironment, thereby inhibiting CRC development in mice51. This evidence concerns the gene IL1RL1 and colorectal carcinoma.